Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- article scientifique publié en 2010 (fr)
- наукова стаття, опублікована в січні 2010 (uk)
- im Januar 2010 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 2010 (ast)
- scientific article published on 05 January 2010 (en)
|
publication date
| |
publication date
| |
exact match
| |
exact match
| |
cites work
| |
cites work
| - ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
- American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
- Chemotherapy-Induced Nausea and Vomiting
- The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St
- Incidence of chemotherapy-induced nausea and emesis after modern antiemetics
- Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron
- Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
- Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
- Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial
- A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
- Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects
- Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study
- Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer
- The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial
- Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice
- Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.
- Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity.
|
author name string
| |
author name string
| - Lili Zhang
- Cheng Huang
- Hong Shen
- Qiang Chen
- Zhiqiang Wang
- Jinghui Wang
- Tongyu Lin
- Jianjin Huang
- Shucai Zhang
- Weihua Tian
- Juntian Zhou
- Liangxi Pan
|
rdfs:label
| - Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (en)
- Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (nl)
|
skos:prefLabel
| - Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (en)
- Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (nl)
|
name
| - Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (en)
- Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (nl)
|
title
| |
title
| - Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1007/S12032-009-9398-2
|
Dimensions Publication ID
| |
Dimensions Publication ID
| |
is about
of | |